journal article·2016-02-17

Synergistic antiproliferative effects of methotrexate-loaded smart silica nanocomposites in MDA-MB-231 breast cancer cells

Neda Alidadiyani, Roya Salehi, Shahrooz Ghaderi, Nasser Samadi, Soodabeh Davaran

Publisher page

Abstract

In this study, the ability of methotrexate (MTX)-loaded stimuli-responsive novel silica nanocomposites (MSNs) (with mean diameter of ± 60 nm) in the induction of apoptosis, and change in the Bax/Bcl-2 mRNA levels, were investigated. MTT assay and RT -PCR analysis were performed on MDA-MB-231 breast cancer cells, to evaluate their anti-proliferative, apoptotic and anti-apoptotic effects. MTX-loaded MSNs caused marked decrease in the percentage of viable cells, with a significant down-regulation in the level of expression of the anti-apoptotic gene (Bcl-2), and up-regulation in the apoptotic gene (Bax). MTX-loaded MSNs increased the efficacy of the chemotherapeutic agents in the inhibition of cell proliferation and induction of apoptosis.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Cell death mechanisms and regulation · Retinoids in leukemia and cellular processes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Department of Biochemistry and Clinical Laboratories, Faculty of Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran

School of Advanced Medical Science, Tabriz University of Medical Sciences, Tabriz, Iran

Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran

Department of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran

References (35)

Show source-provided references
1. 10.1177/096032711245920610.1177/0960327112459206 ↗
2. 10.1016/j.taap.2011.12.02010.1016/j.taap.2011.12.020 ↗
3. 10.1016/j.tox.2011.02.01010.1016/j.tox.2011.02.010 ↗
4. 10.1016/j.tox.2010.07.01010.1016/j.tox.2010.07.010 ↗
5. 10.1056/NEJMoa05051810.1056/NEJMoa050518 ↗
6. 10.18433/J30C7D10.18433/J30C7D ↗
7. 10.1158/1078-0432.CCR-07-144110.1158/1078-0432.CCR-07-1441 ↗
8. 10.1074/jbc.274.45.3209910.1074/jbc.274.45.32099 ↗
9. 10.1038/nrc156610.1038/nrc1566 ↗
10. Gaies E · Drug Metab Toxicol · 2012 · 3 · 1000125
11. Ghanbari P · Appl Biochem Biotechnol · 2014 · 6 · 1125
12. 10.1146/annurev.med.53.082901.10392910.1146/annurev.med.53.082901.103929 ↗
13. 10.3892/or_0000096310.3892/or_00000963 ↗
14. 10.1096/fj.05-4288fje10.1096/fj.05-4288fje ↗
15. 10.1677/erc.0.006002910.1677/erc.0.0060029 ↗
16. 10.1021/cm051014c10.1021/cm051014c ↗
17. 10.1039/C3CS60433K10.1039/C3CS60433K ↗
18. 10.2174/09298671280166117610.2174/092986712801661176 ↗
19. Napierska D · . · 2012 · 25 · 828
20. 10.1016/j.addr.2005.09.01410.1016/j.addr.2005.09.014 ↗
21. 10.1093/nar/30.9.e3610.1093/nar/30.9.e36 ↗
22. 10.1021/ja046275m10.1021/ja046275m ↗
23. Rani D · J Indian Inst Sci · 2012 · 99 · 188
24. 10.1080/15685551.2013.84047510.1080/15685551.2013.840475 ↗
25. 10.3109/10717544.2013.83871410.3109/10717544.2013.838714 ↗
26. 10.1038/sj.onc.120600410.1038/sj.onc.1206004 ↗
27. 10.1002/smll.20090235510.1002/smll.200902355 ↗
28. 10.3109/1061186X.2013.87664510.3109/1061186X.2013.876645 ↗
29. 10.1080/00914037.2013.85423410.1080/00914037.2013.854234 ↗
30. 10.1080/15685551.2013.77130310.1080/15685551.2013.771303 ↗
31. 10.1016/j.biochi.2010.08.00210.1016/j.biochi.2010.08.002 ↗
32. 10.1016/j.tiv.2011.06.01210.1016/j.tiv.2011.06.012 ↗
33. 10.1007/s11095-012-0766-910.1007/s11095-012-0766-9 ↗
34. 10.1074/jbc.M10318120010.1074/jbc.M103181200 ↗
35. 10.1016/j.bmcl.2010.07.02410.1016/j.bmcl.2010.07.024 ↗